Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study-Reference-Cited by-全球学者库

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

Published:2015-03 Issue:3 Volume:62 Page:617-624
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Vitale Alessandro,Burra Patrizia,Frigo Anna Chiara,Trevisani Franco,Farinati Fabio,Spolverato Gaya,Volk Michael,Giannini Edoardo G.,Ciccarese Francesca,Piscaglia Fabio,Rapaccini Gian Lodovico,Di Marco Mariella,Caturelli Eugenio,Zoli Marco,Borzio Franco,Cabibbo Giuseppe,Felder Martina,Gasbarrini Antonio,Sacco Rodolfo,Foschi Francesco Giuseppe,Missale Gabriele,Morisco Filomena,Svegliati Baroni Gianluca,Virdone Roberto,Cillo Umberto

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

2. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions;Bolondi;Semin Liver Dis,2012

3. Model to estimate survival in ambulatory patients with hepatocellular carcinoma;Yang;Hepatology,2012

4. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group;Torzilli;Ann Surg,2013

5. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study;Vitale;Lancet Oncol,2011

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02

2. Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis;Frontiers in Oncology;2024-01-11

3. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis;Frontiers in Immunology;2024-01-08

4. Comparative analysis of radiomics and deep-learning algorithms for survival prediction in hepatocellular carcinoma;Scientific Reports;2024-01-05

5. A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy;Journal of Hepatocellular Carcinoma;2024-01